Kazuto Kato: the ethics of editing humanity
By Gary Humphreys,
Bulletin of the World Health Organization
| 09. 01. 2021
Photo from Kazuto Kato’s biography at
University of Oxford’s Faculty of Law
Gary Humphreys talks to Kazuto Kato about the ethical and societal challenges posed by biotechnologies that allow for the editing of the human genome.
Q: You started out working in developmental biology. How did you become interested in the field of ethics and governance of biomedicine?
A: As a student, I always had a broad interest in the societal issues related to biological science and its application and was actually a member of a student club that focused on such issues. I was also encouraged to look at issues outside the laboratory by my uncle, Professor Shuzo Nishimura, a pioneer in the field of health economics in Japan. Of course, I also had nine years at Kyoto University and four years at the University of Cambridge with Sir John Gurdon studying biology, with a focus on stem cell biology and genomics. This background has helped me navigate what is sometimes complex terrain.
Q: Given that complexity, can you start by giving our readers a simple definition of genomics...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...